ABSTRACT
Adenine nucleotide translocase (ANT) isoforms are mitochondrial proteins encoded by nuclear DNA that catalyze the exchange of ATP generated in the mitochondria for ADP produced in the cytosol. The aim of this study was to determine the role of the transcriptional coactivator PGC-1α (peroxisome proliferator-activated receptor-γ [PPAR-γ] coactivator 1α), a master regulator of mitochondrial oxidative metabolism, in the regulation of the expression of ANT isoform genes and to identify the transcription factors involved. We found that PGC-1α overexpression induced the expression of all ANT human and mouse isoforms but to different degrees. The transcription factor ERRα was involved in PGC-1α-induced expression of all human ANT isoforms (hANT1-3) in HeLa cells as well as in the regulation of mouse isoforms (mANT1-2) in C2C12 myotubes and 3T3-L1 adipocytes, even though ANT isoforms have important physiological differences and are regulated in a tissue-specific manner. In addition to ERRα, PPARδ and mTOR pathways were involved in the induction of mANT1-2 by PGC-1α in C2C12 myotubes, while PPARγ was involved in PGC-1α-regulation of mANT1-2 in 3T3-L1 adipocytes. Furthermore, the regulation of mANT genes by PGC-1α was also observed in vivo in knockout mouse models lacking PGC-1α. In summary, our results show that the regulation of genes encoding ANT isoforms is controlled by PGC-1α through different transcription factors depending on cell type.
Subject(s)
Mitochondria/metabolism , Mitochondrial ADP, ATP Translocases/genetics , Protein Isoforms/biosynthesis , Transcription Factors/genetics , 3T3-L1 Cells , Animals , Gene Expression Regulation , HeLa Cells , Humans , Mice , Mitochondrial ADP, ATP Translocases/biosynthesis , PPAR gamma/biosynthesis , PPAR gamma/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Receptors, Estrogen/biosynthesis , Receptors, Estrogen/metabolism , Transcription Factors/biosynthesis , Transcription Factors/metabolism , ERRalpha Estrogen-Related ReceptorABSTRACT
FGF21 is a novel metabolic regulator involved in the control of glucose homeostasis, insulin sensitivity, and ketogenesis. The liver has been considered the main site of production and release of FGF21 into the blood. Here, we show that, after thermogenic activation, brown adipose tissue becomes a source of systemic FGF21. This is due to a powerful cAMP-mediated pathway of regulation of FGF21 gene transcription. Norepinephrine, acting via ß-adrenergic, cAMP-mediated, mechanisms and subsequent activation of protein kinase A and p38 MAPK, induces FGF21 gene transcription and also FGF21 release in brown adipocytes. ATF2 binding to the FGF21 gene promoter mediates cAMP-dependent induction of FGF21 gene transcription. FGF21 release by brown fat in vivo was assessed directly by analyzing arteriovenous differences in FGF21 concentration across interscapular brown fat, in combination with blood flow to brown adipose tissue and assessment of FGF21 half-life. This analysis demonstrates that exposure of rats to cold induced a marked release of FGF21 by brown fat in vivo, in association with a reduction in systemic FGF21 half-life. The present findings lead to the recognition of a novel pathway of regulation the FGF21 gene and an endocrine role of brown fat, as a source of FGF21 that may be especially relevant in conditions of activation of thermogenic activity.
Subject(s)
Adipose Tissue, Brown/metabolism , Endocrine Glands/metabolism , Fibroblast Growth Factors/biosynthesis , Gene Expression Regulation/physiology , Thermogenesis/physiology , Adipose Tissue, Brown/cytology , Animals , Cells, Cultured , Cold Temperature , Cyclic AMP/genetics , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/genetics , Cyclic AMP-Dependent Protein Kinases/metabolism , Endocrine Glands/cytology , Enzyme Activation/physiology , Fibroblast Growth Factors/genetics , Male , Mice , Mice, Mutant Strains , Rats , Rats, Wistar , Transcription, Genetic/physiology , p38 Mitogen-Activated Protein Kinases/genetics , p38 Mitogen-Activated Protein Kinases/metabolismABSTRACT
BACKGROUND/AIMS: Uncoupling protein-3 (UCP3) is expressed in liver only under conditions of high fatty acid catabolism. However, the specific role of UCP3 in liver mitochondria and overall hepatic function is still poorly known. METHODS: A model of "in vivo" induction of UCP3 expression in mouse liver mitochondria via a tail-vein injection of a recombinant adenoviral vector was developed. The effects on liver mitochondrial bioenergetics and permeability transition, liver gene expression, and systemic metabolism were then determined. RESULTS: UCP3 expression in liver did not cause basal, non-specific, uncoupling but led to a stimulation of palmitate-induced state 4 respiration. UCP3 expression in liver also caused an increase in the expression of certain genes involved in lipid catabolism and metabolic response to starvation (e.g. medium chain acyl-CoA-dehydrogenase or peroxisome proliferator-activated receptor-gamma co-activator-1alpha). UCP3 also conferred to liver mitochondria an enhanced sensitivity to classical inducers of permeability transition, such as calcium and carboxyatractylate. CONCLUSION: UCP3 expression in liver exerts direct actions on mitochondrial activity, favoring fatty acid-induced uncoupling and sensitizing mitochondria to permeability transition, as well as causing retrograde signaling to nuclear gene expression consistent with favoring lipid catabolism and oxidative metabolism.
Subject(s)
Fatty Acids/pharmacology , Gene Expression/drug effects , Ion Channels/metabolism , Mitochondria, Muscle/metabolism , Mitochondrial Proteins/metabolism , 3-Hydroxybutyric Acid/blood , Adenoviridae/genetics , Animals , Blood Glucose/metabolism , Cell Respiration/drug effects , Cell Respiration/genetics , Dietary Fats/pharmacology , Fatty Acids, Nonesterified/blood , Glutathione Peroxidase/metabolism , Humans , Ion Channels/genetics , Lipid Metabolism/genetics , Male , Mice , Mice, Inbred C57BL , Mitochondria, Liver/genetics , Mitochondria, Liver/metabolism , Mitochondria, Muscle/genetics , Mitochondrial Proteins/genetics , Mitochondrial Swelling/drug effects , Oxidation-Reduction , Oxidative Stress , Oxygen Consumption/drug effects , Permeability/drug effects , Subcellular Fractions/metabolism , Superoxide Dismutase/metabolism , Transgenes , Triglycerides/blood , Uncoupling Protein 3ABSTRACT
The beneficial effects of brown adipose tissue (BAT) are attributed to its capacity to oxidize metabolites and produce heat, but recent data suggest that secretory properties of BAT may also be involved. Here, we identify the chemokine CXCL14 (C-X-C motif chemokine ligand-14) as a novel regulatory factor secreted by BAT in response to thermogenic activation. We found that the CXCL14 released by brown adipocytes recruited alternatively activated (M2) macrophages. Cxcl14-null mice exposed to cold showed impaired BAT activity and low recruitment of macrophages, mainly of the M2 phenotype, into BAT. CXCL14 promoted the browning of white fat and ameliorated glucose/insulin homeostasis in high-fat-diet-induced obese mice. Impairment of type 2 cytokine signaling, as seen in Stat6-null mice, blunts the action of CXCL14, promoting adipose tissue browning. We propose that active BAT is a source of CXCL14, which concertedly promotes adaptive thermogenesis via M2 macrophage recruitment, BAT activation, and the browning of white fat.
Subject(s)
Adipose Tissue, Brown/metabolism , Chemokines, CXC/metabolism , Obesity/metabolism , Thermogenesis , Adipocytes, Brown/metabolism , Adult , Animals , Cells, Cultured , Energy Metabolism , Female , Glucose/metabolism , Humans , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Middle Aged , RAW 264.7 Cells , Rats, WistarABSTRACT
Human cells express four mitochondrial adenine nucleotide translocase (hANT) isoforms that are tissue-specific and developmentally regulated. hANT1 is mainly expressed in terminally differentiated muscle cells; hANT2 is growth-regulated and is upregulated in highly glycolytic and proliferative cells; and hANT3 is considered to be ubiquitous and non-specifically regulated. Here, we studied how the expression of hANT isoforms is regulated by proliferation and in response to metabolic stimuli, and examined the metabolic consequences of their silencing and overexpression. In HeLa and HepG2 cells, expression of hANT3 was upregulated by shifting metabolism towards oxidation or by slowed growth associated with contact inhibition or growth-factor deprivation, indicating that hANT3 expression is highly regulated. Under these conditions, changes in hANT2 mRNA expression were not observed in either HeLa or HepG2 cells, whereas in SGBS preadipocytes (which, unlike HeLa and HepG2 cells, are growth-arrest-sensitive cells), hANT2 mRNA levels decreased. Additionally, overexpression of hANT2 promoted cell growth and glycolysis, whereas silencing of hANT3 decreased cellular ATP levels, limited cell growth and induced a stress-like response. Thus, cancer cells require both hANT2 and hANT3, depending on their proliferation status: hANT2 when proliferation rates are high, and hANT3 when proliferation slows.
Subject(s)
Energy Metabolism , Gene Expression Regulation , Mitochondrial ADP, ATP Translocases/genetics , Mitochondrial ADP, ATP Translocases/metabolism , Cell Cycle Checkpoints/genetics , Cell Proliferation , Gene Knockdown Techniques , Gene Silencing , Glycolysis , Glycosylation , HeLa Cells , Hep G2 Cells , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Isoenzymes , Oxidation-Reduction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Stress, Physiological/geneticsABSTRACT
Adenine nucleotide translocases (ANTs) are mitochondrial proteins encoded by nuclear DNA that catalyze the exchange of ATP generated in the mitochondria for ADP produced in cytosol. There are four ANT isoforms in humans (hANT1-4) and three in mice (mANT1, mANT2 and mANT4), all encoded by distinct genes. The aim of this study was to quantify expression of ANT isoform genes during the adipogenesis of mouse 3T3-L1 and human Simpson-Golabi-Behmel syndrome (SGBS)-derived preadipocytes. We also studied the effects of the adipogenesis regulators, insulin and rosiglitazone, on ANT isoform expression in differentiated adipocytes and examined the expression of ANT isoforms in subcutaneous and visceral white adipose tissue (WAT) from mice and humans. We found that adipogenesis was associated with an increase in the expression of ANT isoforms, specifically mANT2 in mouse 3T3-L1 cells and hANT3 in human SGBS cells. These changes could be involved in the increases in oxidative metabolism and decreases in lactate production observed during differentiation. Insulin and rosiglitazone induced mANT2 gene expression in mature 3T3-L1 cells and hANT2 and hANT3 gene expression in SGBS adipocytes. Furthermore, human WAT expressed greater amounts of hANT3 than hANT2, and the expression of both of these isoforms was greater in subcutaneous WAT than in visceral WAT. Finally, inhibition of ANT activity by atractyloside or bongkrekic acid impaired proper adipocyte differentiation. These results suggest that changes in the expression of ANT isoforms may be involved in adipogenesis in both human and mouse WAT.
Subject(s)
Adipogenesis , Mitochondrial ADP, ATP Translocases/metabolism , 3T3-L1 Cells , Animals , Cell Differentiation , Gene Expression , Humans , Mice , Mitochondrial ADP, ATP Translocases/genetics , Protein Isoforms/genetics , Protein Isoforms/metabolism , Subcutaneous Fat/metabolismABSTRACT
FGF21 is a hormonal factor with important functions in the control of metabolism. FGF21 is found in rodent and human milk. Radiolabeled FGF21 administered to lactating dams accumulates in milk and is transferred to neonatal gut. The small intestine of neonatal (but not adult) mice highly expresses ß-Klotho in the luminal area. FGF21-KO pups fed by FGF21-KO dams showed decreased expression and circulating levels of incretins (GIP and GLP-1), reduced gene expression of intestinal lactase and maltase-glucoamylase, and low levels of galactose in plasma, all associated with a mild decrease in body weight. When FGF21-KO pups were nursed by wild-type dams (expressing FGF21 in milk), intestinal peptides and digestive enzymes were up-regulated, lactase enzymatic activity was induced, and galactose levels and body weight were normalized. Neonatal intestine explants were sensitive to FGF21, as evidenced by enhanced ERK1/2 phosphorylation. Oral infusion of FGF21 into neonatal pups induced expression of intestinal hormone factors and digestive enzymes, lactase activity and lactose absorption. These findings reveal a novel role of FGF21 as a hormonal factor contributing to neonatal intestinal function via its presence in maternal milk. Appropriate signaling of FGF21 to neonate is necessary to ensure optimal digestive and endocrine function in developing intestine.
Subject(s)
Fibroblast Growth Factors/metabolism , Intestinal Mucosa/metabolism , Milk/metabolism , Administration, Oral , Animals , Animals, Newborn , Body Weight , Female , Fibroblast Growth Factors/administration & dosage , Fibroblast Growth Factors/blood , Galactose/blood , Gene Expression Regulation, Developmental , Glucuronidase , Hormones/genetics , Hormones/metabolism , Humans , Incretins/metabolism , Intestinal Absorption/drug effects , Intestines/enzymology , Klotho Proteins , Lactase/metabolism , Lactation , Mice, Knockout , Milk, Human/metabolism , Models, Biological , RatsABSTRACT
Mitochondrial adenine nucleotide translocase 1 (ANT1), but not ANT2, can dominantly induce apoptosis. Nothing is known, however, about the apoptotic activity of ANT3. We have transfected HeLa cells with the three human ANT isoforms to compare their potential as inducers of apoptosis. Transient overexpression of ANT3 resulted, like ANT1, in apoptosis as shown by an increase in the sub-G1 fraction, annexin V staining, low DeltaPsi(m), and activation of caspases 9 and 3. Moreover, the apoptosis produced by ANT3 was inhibited by bongkrekic acid and by cyclosporin A. The pro-apoptotic activities of the ANT1 and ANT3 isoforms contrast with the lack of apoptotic activity of ANT2. This finding may help to identify the specific factors associated with the pro-apoptotic activities of ANT isoforms.
Subject(s)
Adenine Nucleotide Translocator 3/metabolism , Apoptosis/drug effects , Adenine Nucleotide Translocator 3/drug effects , Adenine Nucleotide Translocator 3/genetics , Bongkrekic Acid/pharmacology , Caspases/metabolism , Cyclosporine/pharmacology , Enzyme Inhibitors/pharmacology , Gene Expression , HeLa Cells , Humans , Membrane Potentials , Mitochondria/chemistry , Mitochondria/physiology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Time Factors , TransfectionABSTRACT
We examined the apoptotic and anti-proliferative effects of all-trans retinoic acid (atRA) in HeLa cells. Our results demonstrated that HeLa cells were more sensitive to the anti-proliferative effects of atRA than to its apoptotic effects. Furthermore, we demonstrated that caspase inhibition attenuates cell death but does not alter the atRA-dependent reduction in cell proliferation, which suggests that atRA-induced apoptosis is independent of the arrest in cell proliferation. To check whether ANT proteins mediated these atRA effects, we transiently transfected cells with expression vectors encoding for individual ANT (adenine nucleotide translocase 1-3). Our results revealed that ANT1 and ANT3 over-expressing HeLa cells increased their atRA sensitivity. Thus, our results not only demonstrate the different functional activities of ANT isoforms, but also contribute to a better understanding of the properties of atRA as an anti-tumoral agent used in cancer therapy.
Subject(s)
Adenine Nucleotide Translocator 1/metabolism , Adenine Nucleotide Translocator 3/metabolism , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Proliferation/drug effects , HeLa Cells/drug effects , Tretinoin/pharmacology , Dose-Response Relationship, Drug , HumansABSTRACT
We investigated the effects of retinoic acids on mitochondrial permeability transition (MPT) measured as changes in rhodamine 123 fluorescence from both isolated heart mitochondria and HeLa cells. We report that all-trans-retinoic acid (atRA), 9-cis-retinoic acid, and 13-cis-retinoic acid induce a drop in mitochondrial membrane potential in isolated mitochondria. The atRA effect was done through the induction of MPT because it was dependent on Ca(2+), in a synergic mechanism, and inhibited by cyclosporin A (CsA). Furthermore, atRA also opened MPT in vivo, because treatment of HeLa cells with atRA results in a CsA-sensitive drop of mitochondrial membrane potential. We demonstrated for the first time that retinoic acids inhibit adenine nucleotide translocase (ANT) activity in heart and liver mitochondria. Kinetic studies revealed atRA as an uncompetitive inhibitor of ANT. Photoaffinity labeling of mitochondrial proteins with [3H]atRA demonstrated the binding of a 31-kDa protein to atRA. This protein was identified as ANT because the presence of carboxyatractyloside, a specific ANT inhibitor, prevented labeling. The specific photolabeling of ANT was also prevented in a concentration-dependent manner by nonlabeled atRA, whereas palmitic acid was ineffective. This study indicates that specific interaction between atRA and ANT takes place regulating MPT opening and adenylate transport. These observations establish a novel mechanism for atRA action, which could control both energetic and apoptotic mitochondrial processes in situations such as retinoic acid treatment.
Subject(s)
Ion Channels/biosynthesis , Mitochondria, Heart/drug effects , Mitochondrial ADP, ATP Translocases/antagonists & inhibitors , Tretinoin/pharmacology , Animals , Binding Sites , Cattle , HeLa Cells , Humans , Membrane Potentials/drug effects , Mitochondria, Heart/metabolism , Mitochondria, Heart/physiology , Mitochondria, Liver/drug effects , Mitochondria, Liver/enzymology , Mitochondrial ADP, ATP Translocases/metabolism , Mitochondrial Membrane Transport Proteins , Mitochondrial Permeability Transition PoreABSTRACT
Overexpression of adenine nucleotide translocase-1 (ANT1) is known to induce apoptosis (Bauer, M. K., Schubert, A., Rocks, O., and Grimm, S. (1999) J. Cell Biol. 147, 1493-1501), but the mechanisms involved remain unclear. In this study we show that ANT1 overexpression results in a recruitment of the IkappaBalpha-NF-kappaB complex into mitochondria, with a coincident decrease in nuclear NF-kappaB DNA binding activity. In this situation, NF-kappaB transcriptionally regulated genes with antiapoptotic activity, such as Bcl-XL, MnSOD2, and c-IAP2, are down-regulated, and consequently, cells are sensitized to apoptosis. Accordingly, co-expression of p65 partially interferes with the proapoptotic effect of ANT1 overexpression. Despite the high identity of the two isoforms, overexpression of ANT2 does not exert an apoptotic effect; this lack of apoptotic activity is correlated with the absence of mitochondrial IkappaBalpha-NF-kappaB recruitment or changes in NF-kappaB activity. Thus, we propose that the mitochondrial recruitment of NF-kappaB observed following ANT1 overexpression has an important role in ANT1 proapoptotic activity.
Subject(s)
Adenine Nucleotide Translocator 1/metabolism , Adenine Nucleotide Translocator 2/metabolism , Apoptosis , Mitochondria/metabolism , NF-kappa B/metabolism , Annexin A5/pharmacology , Cell Nucleus/metabolism , Coloring Agents/pharmacology , Cytosol/metabolism , DNA/metabolism , DNA, Complementary/metabolism , Down-Regulation , Endopeptidase K/pharmacology , Flow Cytometry , Fluorescein-5-isothiocyanate , HeLa Cells , Humans , Immunoblotting , Membrane Potentials , Mitochondria/pathology , Plasmids/metabolism , Protein Binding , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Subcellular Fractions , Transcription, Genetic , TransfectionABSTRACT
To gain insight into the immunogenicity of mitochondrial adenine nucleotide translocase (ANT), we raised antibodies against purified bovine heart ANT by induction of ascitic fluid in male Balb/c mice. We identified the antigenic determinants detected by these antibodies by (1) immunodetection of GST-ANT fusion proteins and selected partial constructs of ANT, (2) immunodetection of chemically synthesized overlapping peptides on solid support, and (3) back-titration ELISA. Results revealed a short epitope spreading of the antibodies, resulting in a small number of antigenic determinants. Thus, each antibody detects one or two major epitopes located in the putative hydrophilic loops M2 and M3. No evidence for the antigenicity of the first 133 amino acids of ANT was obtained. These well-characterized antibodies were used to study the topography of the membrane-bound ANT by back-titration ELISA with mitochondrial membranes. We demonstrated that amino acids 145-150 and 230-237 are fully accessible to the antibodies in native ANT, whereas regions 133-140 and 244-251 are not. Furthermore, we used mitochondria devoid of the outer membrane (mitoplasts) and inside-out submitochondrial particles (SMP) to establish the matrix or cytosolic orientation of loops M2 and M3. The results clearly show that these loops have a matrix orientation and thus support the six transmembrane segment model of ANT topography in the inner mitochondrial membrane.
Subject(s)
Antibodies/metabolism , Intracellular Membranes/enzymology , Membrane Proteins/metabolism , Mitochondria, Heart/enzymology , Mitochondrial ADP, ATP Translocases/immunology , Mitochondrial ADP, ATP Translocases/metabolism , Animals , Ascitic Fluid/immunology , Ascitic Fluid/metabolism , Binding Sites, Antibody , Binding, Competitive/immunology , Cattle , Enzyme-Linked Immunosorbent Assay/methods , Epitope Mapping/methods , Glutathione Transferase/immunology , Glutathione Transferase/metabolism , Intracellular Membranes/immunology , Male , Membrane Proteins/immunology , Mice , Mice, Inbred BALB C , Mitochondria, Heart/immunology , Protein Conformation , Protein Structure, Secondary , Protein Structure, Tertiary , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolismABSTRACT
Mitochondrial adenine nucleotide translocase (ANT) is a specific target for the autoantibody response in idiopathic dilated cardiomyopathy (IDCM). We have undertaken an epitope analysis of ANT in IDCM by immunoblot with recombinant GST-ANT fusion proteins and with cellulose-bound decapeptides of human ANT1. Forty-five patients with IDCM, 17 patients with ischemic left ventricle dysfunction (LVD) and 20 controls were analyzed for circulating antibodies against ANT (AAb-ANT). Sixteen of the 45 (36%) IDCM patients showed AAb-ANT above controls. In immunoblots, AAb-ANT detected purified bovine heart ANT and GST-ANT1 and GST-ANT2 isoforms and, less frequently, the GST-ANT3 isoform. A construct lacking the last 146 amino acids did not react with AAb-ANT, indicating that the main epitopes are in the C-terminal 146 amino acids. Immunodetection of decapeptides covering this region shows that AAb-ANT detects at least three epitopes, demonstrating that ANT is the primary target of AAb-ANT. The most significant epitopes belong to the M2 and M3 hydrophilic loops of ANT suggesting that apart from being essential for its activity, these loops are highly immunogenic.